Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.50
+0.50 (0.71%)
At close: Dec 5, 2025
5.22%
Market Cap3.51B
Revenue (ttm)n/a
Net Income (ttm)-117.07M
Shares Out49.80M
EPS (ttm)-2.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,107
Average Volume10,623
Open69.90
Previous Close70.00
Day's Range68.10 - 70.90
52-Week Range57.00 - 81.60
Beta-0.03
RSI50.60
Earnings DateNov 14, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.